Loss-of-Function Mutations of BCOR Are an Independent Marker of Adverse Outcomes in Intensively Treated Patients with Acute Myeloid Leukemia. - Eckardt, Jan-Niklas; Stasik, Sebastian; Kramer, Michael; Röllig, Christoph; Krämer, Alwin; Scholl, Sebastian; Hochhaus, Andreas; Crysandt, Martina; Brümmendorf, Tim H.; Naumann, Ralph; Steffen, Björn; Kunzmann, Volker; et al. (Cancers, 2021)